• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
COVID-19 and the Response of Transplant Centers: the Global Response with an Emphasis on the Kidney Recipient.2019冠状病毒病与移植中心的应对:以肾移植受者为重点的全球应对措施
Curr Transplant Rep. 2021;8(3):163-182. doi: 10.1007/s40472-021-00330-5. Epub 2021 Jun 29.
2
OPTN/SRTR 2020 Annual Data Report: Kidney.OPTN/SRTR 2020 年度数据报告:肾脏。
Am J Transplant. 2022 Mar;22 Suppl 2:21-136. doi: 10.1111/ajt.16982.
3
OPTN/SRTR 2021 Annual Data Report: Kidney.OPTN/SRTR 2021 年度数据报告:肾脏。
Am J Transplant. 2023 Feb;23(2 Suppl 1):S21-S120. doi: 10.1016/j.ajt.2023.02.004.
4
Pediatric Kidney Transplantation in the Middle East: Challenges and Solutions.中东地区小儿肾移植:挑战与对策。
Exp Clin Transplant. 2022 May;20(Suppl 3):7-14. doi: 10.6002/ect.PediatricSymp2022.L2.
5
OPTN/SRTR 2022 Annual Data Report: Kidney.OPTN/SRTR 2022 年度数据报告:肾脏。
Am J Transplant. 2024 Feb;24(2S1):S19-S118. doi: 10.1016/j.ajt.2024.01.012.
6
[Kidney transplantation from Covid-19 positive deceased donor: what are the consequences for recipients?].[来自新冠病毒检测呈阳性的已故供体的肾移植:对受者有何影响?]
Urologiia. 2021 Sep(4):87-92.
7
COVID-19 and Living Donor Kidney Transplantation in Naples during the Pandemic.COVID-19 与大流行期间那不勒斯的活体供肾移植
Biomed Res Int. 2020 Oct 15;2020:5703963. doi: 10.1155/2020/5703963. eCollection 2020.
8
Telehealth Use by Living Kidney Donor Transplant Programs During the COVID-19 Pandemic and Beyond: a Practical Approach.活体肾供体移植项目在 COVID-19 大流行期间及之后的远程医疗应用:一种实用方法。
Curr Transplant Rep. 2021;8(4):257-262. doi: 10.1007/s40472-021-00339-w. Epub 2021 Nov 17.
9
Liver and Kidney Transplant During a 6-Month Period in the COVID-19 Pandemic: A Single-Center Experience.新冠疫情期间6个月内的肝肾移植:单中心经验
Exp Clin Transplant. 2020 Oct;18(5):564-571. doi: 10.6002/ect.2020.0388.
10
OPTN/SRTR 2022 Annual Data Report: Liver.OPTN/SRTR 2022 年度数据报告:肝脏。
Am J Transplant. 2024 Feb;24(2S1):S176-S265. doi: 10.1016/j.ajt.2024.01.014.

引用本文的文献

1
Outcomes of Patients Receiving a Kidney Transplant or Remaining on the Transplant Waiting List at the Epicentre of the COVID-19 Pandemic in Europe: An Observational Comparative Study.欧洲新冠疫情中心接受肾移植或仍在移植等待名单上的患者的结局:一项观察性比较研究。
Pathogens. 2022 Oct 3;11(10):1144. doi: 10.3390/pathogens11101144.
2
Effect of a Third Dose of SARS-CoV-2 mRNA BNT162b2 Vaccine on Humoral and Cellular Responses and Serum Anti-HLA Antibodies in Kidney Transplant Recipients.第三剂SARS-CoV-2 mRNA BNT162b2疫苗对肾移植受者体液和细胞免疫反应及血清抗HLA抗体的影响
Vaccines (Basel). 2022 Jun 9;10(6):921. doi: 10.3390/vaccines10060921.
3
Solid Organ Transplantation in SARS-CoV-2 Recovered Transplant Candidates: a Comprehensive Review of Recent Literature.SARS-CoV-2康复的移植候选者的实体器官移植:近期文献综述
Curr Transplant Rep. 2022;9(2):95-107. doi: 10.1007/s40472-022-00362-5. Epub 2022 Mar 9.
4
The COVID-19 pandemic and organ donation and transplantation: ethical issues.COVID-19 大流行与器官捐献和移植:伦理问题。
BMC Med Ethics. 2021 Oct 21;22(1):142. doi: 10.1186/s12910-021-00711-6.

本文引用的文献

1
Outcomes of Renal Transplant Recipients With SARS-CoV-2 Infection in the Eye of the Storm: A Comparative Study With Waitlisted Patients.SARS-CoV-2 感染肾移植受者的结局:与等待移植患者的对比研究
Transplantation. 2021 Jan 1;105(1):115-120. doi: 10.1097/TP.0000000000003406.
2
Oxford-AstraZeneca COVID-19 vaccine efficacy.牛津大学-阿斯利康新冠疫苗的效力
Lancet. 2021 Jan 9;397(10269):72-74. doi: 10.1016/S0140-6736(20)32623-4. Epub 2020 Dec 8.
3
COVID-19 infection in kidney transplant recipients at the epicenter of pandemics.COVID-19 感染在疫情中心的肾移植受者中。
Kidney Int. 2020 Dec;98(6):1559-1567. doi: 10.1016/j.kint.2020.10.004. Epub 2020 Oct 16.
4
Biomarkers of Cytokine Release Syndrome Predict Disease Severity and Mortality From COVID-19 in Kidney Transplant Recipients.细胞因子释放综合征的生物标志物可预测肾移植受者 COVID-19 疾病的严重程度和死亡率。
Transplantation. 2021 Jan 1;105(1):158-169. doi: 10.1097/TP.0000000000003480.
5
COVID-19 Outcomes Among Solid Organ Transplant Recipients: A Case-control Study.实体器官移植受者的 COVID-19 结局:一项病例对照研究。
Transplantation. 2021 Jan 1;105(1):128-137. doi: 10.1097/TP.0000000000003447.
6
An initial report from the French SOT COVID Registry suggests high mortality due to COVID-19 in recipients of kidney transplants.法国 SOT COVID 登记处的初步报告显示,COVID-19 导致接受肾移植者的死亡率很高。
Kidney Int. 2020 Dec;98(6):1549-1558. doi: 10.1016/j.kint.2020.08.005. Epub 2020 Aug 24.
7
COVID-19 Infection in Kidney Transplant Recipients: Disease Incidence and Clinical Outcomes.肾移植受者中的 COVID-19 感染:疾病发生率和临床结局。
J Am Soc Nephrol. 2020 Oct;31(10):2413-2423. doi: 10.1681/ASN.2020050639. Epub 2020 Aug 26.
8
Outcomes of critically ill solid organ transplant patients with COVID-19 in the United States.美国 COVID-19 危重症实体器官移植患者的结局。
Am J Transplant. 2020 Nov;20(11):3061-3071. doi: 10.1111/ajt.16280. Epub 2020 Sep 15.
9
Respiratory and Gastrointestinal COVID-19 Phenotypes in Kidney Transplant Recipients.肾移植受者的 COVID-19 呼吸道和胃肠道表型。
Transplantation. 2020 Nov;104(11):2225-2233. doi: 10.1097/TP.0000000000003413.
10
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults.一项在成人中开展的 COVID-19 RNA 疫苗 BNT162b1 的 I/II 期研究。
Nature. 2020 Oct;586(7830):589-593. doi: 10.1038/s41586-020-2639-4. Epub 2020 Aug 12.

2019冠状病毒病与移植中心的应对:以肾移植受者为重点的全球应对措施

COVID-19 and the Response of Transplant Centers: the Global Response with an Emphasis on the Kidney Recipient.

作者信息

Azzi Yorg, Brooks Abigail, Yaffe Hillary, Greenstein Stuart

机构信息

Albert Einstein College of Medicine, Bronx, NY USA.

Montefiore-Einstein Center for Transplantation, Montefiore Medical Center, 111 East 210th Street, Bronx, NY 10467-2401 USA.

出版信息

Curr Transplant Rep. 2021;8(3):163-182. doi: 10.1007/s40472-021-00330-5. Epub 2021 Jun 29.

DOI:10.1007/s40472-021-00330-5
PMID:34221847
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8241407/
Abstract

PURPOSE OF THE REVIEW

In response to the COVID-19 pandemic, vulnerable populations, such as transplant patients, were at greater risk than the regular population. In order to protect these populations, transplant centers enacted new guidelines. We approach this review by looking at how different transplant regions responded to COVID-19 and analyze the unifying themes that have proven invaluable in the subsequent waves.

RECENT FINDINGS

We noticed that most elective surgeries including living donor transplant operations were suspended in most countries. The response to deceased donor transplants varied between countries: in some deceased donor transplants continued with modified donor and recipient criteria, while in other countries this surgery was suspended. There was a general trend of decreasing or holding antimetabolites, treating the virus with hydroxychloroquine and/or azithromycin, and converting outpatient clinics to virtual clinics.

SUMMARY

We learned how to carefully select donors and recipients, tailor immunosuppressant regiments, and implement telemedicine. The kidney recipient population can be effectively managed in times of crisis with appropriate accommodations and measures. This review can be a model for the transplant community for future pandemics.

摘要

综述目的

为应对新冠疫情,移植患者等弱势群体比普通人群面临更大风险。为保护这些人群,移植中心制定了新指南。我们通过研究不同移植地区对新冠疫情的应对方式,并分析在后续疫情浪潮中已证明非常宝贵的统一主题来进行本综述。

最新发现

我们注意到,大多数国家暂停了包括活体供体移植手术在内的大多数择期手术。各国对 deceased donor 移植的应对措施各不相同:在一些国家,deceased donor 移植在修改供体和受体标准后继续进行,而在其他国家,该手术被暂停。普遍趋势是减少或停用抗代谢药物,用羟氯喹和/或阿奇霉素治疗病毒,并将门诊诊所转变为虚拟诊所。

总结

我们学会了如何谨慎选择供体和受体、调整免疫抑制方案以及实施远程医疗。在危机时期,通过适当的调整和措施,可以有效地管理肾移植受者群体。本综述可为移植界应对未来大流行提供一个范例。